Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors ...

A recent study reveals significant gaps in cough management in India, highlighting excessive antibiotic use and a lack of ...

2025年9月16日，个人护理用品公司Kenvue（KVUE）成交额为3.58亿美元，在当日美股中排第324名，成交额较昨日减少21.61%，当日成交量为1967.91万。 Kenvue（KVUE）于2025年9月16日跌0.66%，报18.13美元，该股过去5个交易日跌3.92%，整个9月跌12.46%，年初至今跌15.08%，过去52周跌22.46%。

A recent study highlights improper categorization and treatment of cough in India. It emphasizes the overuse of antibiotics and fixed-dose combinations, urging a scientific approach to evaluation and ...

Stocks are rallying on the expectation that the Federal Reserve will cut interest rates by 25 basis points in September. That ...

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian served as co-counsel to longtime client Boston Basketball Partners, ...

Having had the little Honda dirt bike for just over 2 months and 800 miles I thought it was high time I did a full review of ...

Investing.com -- Barclays downgraded consumer health company Haleon to “equal weight” from “overweight,” cutting its price target to 380p from 430p, citing prolonged weakness in the United States and ...